Currencies: Turkish lira rebounds off historic lows against major currencies

This post was originally published on this site
AFP/Getty Images

A Turkish bounce for the lira

The Turkish lira staged a broad rally against its major counterparts Tuesday following an intense few sessions of unraveling that has sparked concerns of economic contagion.

Most recently, the Turkish lira USDTRY, -4.5260%  was up sharply against the dollar and the euro EURTRY, -4.5725% One dollar bought 6.5327 lira, from 6.8846 late Monday in New York, a gain of nearly 5% for lira. Meanwhile, a euro bought 7.4940 lira, versus 7.9079 lira in the previous session.

On Monday, the Central Bank of the Republic of Turkey introduced measures to boost liquidity in the market, but investors appeared to brush off those efforts, remaining concerned that country’s economic health under President Recep Tayyip Erdogan remains in question. The autocratic leader has placed blame for Turkey’s plunging lira on the U.S., which has imposed sanctions against the nation for its detention of evangelical pastor Andrew Brunson.

Over the weekend, a defiant Erdogan said he had no intention of hiking rates in the country, something that economists and critics feel is needed to alleviate pressures from the rapidly declining currency. The Turkish president also blamed “economic terrorists on social media” for disseminating alleged disinformation about the state of Turkey’s economic condition, during Monday speeches.

The Turkish lira has lost a third of its value in August alone against the U.S. dollar and has declined by about 73% against the currency thus far this year.

Check out: Strategists see 4 ways out of Turkey’s currency crisis

Meanwhile, the dollar, as measured by the ICE U.S. Dollar Index DXY, -0.03% a gauge of the buck against a half-dozen currencies but not including Turkish lira, was flat on the day, holding mostly steady after reaching a nearly 14-month peak in recent days.

The gauge stands at 96.3800. A broader-based dollar index, the WSJ Dollar Index BUXX, -0.18% which measures the buck’s strength against 16 rivals including the lira, was down 0.1% on the session.

Emerging-market currencies, which had fallen in sympathy with the Turkish lira as investors feared a spillover, also have moderated losses and turned higher.

The South African rand USDZAR, -2.2392% and Mexican peso USDMXN, -1.2398%  were both strengthening on the day, with one dollar fetching 14.1294 rand versus 14.4201 late Monday, and 18.9657 Mexican pesos versus 19.1161 a day earlier.

Although concerns that Turkey’s problems could portend difficulties brewing across the complex of EM currencies, which tend to maintain high dollar-denominated debts, others suggest that Ankara’s woes, including inflation and an autocratic leader, are more country specific.

“We don’t doubt that some, or even many of these problems can be found in other countries but, for the most part, we think the problems are pretty specific to Turkey. Perhaps the only one that might require monitoring is the external borrowing issue as US rates rise and the dollar strengthens,” wrote Steven Barrow, currency and fixed-income strategist at Standard Bank in a Tuesday research note.

Countries that maintain a significant amount of debts denominated in dollars and that use local currencies to service those obligations can run into troubles when the greenback’s value escalates rapidly.

Emerging markets have been a focus of concern for investors this year because after declining by 10% last year, the dollar index has advanced by 4.6% in the first eight months of 2018. Moreover, the Federal Reserve is expected to increase rates twice more before the end of the year, perhaps providing a further boost to greenback in a climate where few other countries are tightening monetary policy as aggressively.

Meanwhile, the euro EURUSD, -0.0526%  edged down to $1.1389, compared with $1.1411 late Monday, a decline of about 0.2% against the buck and the British pound GBPUSD, +0.0783%   gained slightly, with one dollar buying $1.2781, compared with $1.2766.

Want news about Europe delivered to your inbox? Subscribe to MarketWatch’s free Europe Daily newsletter. Sign up here.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.